BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18798078)

  • 1. Intravitreal recombinant human erythropoietin: a safety study in rabbits.
    Song BJ; Cai H; Tsai JC; Chang S; Forbes M; Del Priore LV
    Curr Eye Res; 2008 Sep; 33(9):750-60. PubMed ID: 18798078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of single intravitreal rhEPO injection on light-induced retinal injury in rats.
    Gong Y; Qiu Y; Song Z; Gu Q; Wu X; Sun X
    Curr Eye Res; 2011 Aug; 36(8):739-46. PubMed ID: 21780923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits.
    Komarowska I; Heilweil G; Rosenfeld PJ; Perlman I; Loewenstein A
    Retina; 2009 Jan; 29(1):98-105. PubMed ID: 18626418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit.
    Ruiz-Moreno JM; Montero JA; Bayon A; Rueda J; Vidal M
    Exp Eye Res; 2007 Feb; 84(2):342-8. PubMed ID: 17141760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
    Giansanti F; Ramazzotti M; Vannozzi L; Rapizzi E; Fiore T; Iaccheri B; Degl' Innocenti D; Moncini D; Menchini U
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1151-6. PubMed ID: 18326743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal toxicity of intravitreal kenalog in albino rabbits.
    Lang Y; Zemel E; Miller B; Perlman I
    Retina; 2007; 27(6):778-88. PubMed ID: 17621190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.
    Cheng CK; Berger AS; Pearson PA; Ashton P; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):442-53. PubMed ID: 7843913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models.
    Gao H; Pennesi ME; Qiao X; Iyer MN; Wu SM; Holz ER; Mieler WF
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1606-11. PubMed ID: 16565399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravitreal injection of norfloxacin on the retina in pigmented rabbits.
    Tanahashi T; Mochizuki K; Torisaki M; Yamashita Y; Komatsu M; Higashide T; Ogata M
    Lens Eye Toxic Res; 1992; 9(3-4):493-503. PubMed ID: 1301799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal toxicity of indocyanine green in albino rabbits.
    Goldstein M; Zemel E; Loewenstein A; Perlman I
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2100-7. PubMed ID: 16639021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of INS37217, a P2Y(2) receptor agonist, on experimental retinal detachment and electroretinogram in adult rabbits.
    Meyer CH; Hotta K; Peterson WM; Toth CA; Jaffe GJ
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3567-74. PubMed ID: 12407169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of nontoxic concentrations of piperacillin/tazobactam for intravitreal application. An electroretinographic, histopathologic and morphometric analysis.
    Ozkiriş A; Evereklioglu C; Kontaş O; Oner AO; Erkiliç K
    Ophthalmic Res; 2004; 36(3):139-44. PubMed ID: 15103204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of intravitreal hyaluronidase. A clinical and histologic study.
    Gottlieb JL; Antoszyk AN; Hatchell DL; Saloupis P
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2345-52. PubMed ID: 2242999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies.
    Gao H; Pennesi M; Shah K; Qiao X; Hariprasad SM; Mieler WF; Wu SM; Holz ER
    Trans Am Ophthalmol Soc; 2003; 101():183-9; discussion 189. PubMed ID: 14971576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicologic and pharmacokinetic analysis of intravitreal injections of foscarnet, either alone or in combination with ganciclovir.
    Berthe P; Baudouin C; Garraffo R; Hofmann P; Taburet AM; Lapalus P
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1038-45. PubMed ID: 8125715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of the photosensitizer NPe6 following intravitreal injection.
    El-Dessouky ES; Moshfeghi AA; Peyman GA; Yoneya S; Mori K; Kazi AA; Moshfeghi DM
    Ophthalmic Surg Lasers; 2001; 32(4):316-21. PubMed ID: 11475398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical investigation of the retinal biocompatibility of six novel vital dyes for chromovitrectomy.
    Rodrigues EB; Penha FM; Farah ME; de Paula Fiod Costa E; Maia M; Dib E; Bottós J; Freymuller E; Furlani B; Meyer CH; Magalhães O; Lima-Filho AA; Safatle A
    Retina; 2009 Apr; 29(4):497-510. PubMed ID: 19174713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular toxicity of intravitreal tacrolimus.
    Passos E; Genaidy MM; Peyman GA
    Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rabbit retinal neovascularization induced by latex angiogenic-derived fraction: an experimental model.
    Sampaio RB; Mendonca RJ; Simioni AR; Costa RA; Siqueira RC; Correa VM; Tedesco AC; Haddad A; Coutinho Netto J; Jorge R
    Curr Eye Res; 2010 Jan; 35(1):56-62. PubMed ID: 20021255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.